Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation
- 11 November 2005
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 337 (1), 382-385
- https://doi.org/10.1016/j.bbrc.2005.09.060
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A potential role for extracellular nitric oxide generation in cGMP‐independent inhibition of human platelet aggregation: biochemical and pharmacological considerationsBritish Journal of Pharmacology, 2005
- Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failureThe American Journal of Cardiology, 2004
- Treatment of Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover studyJournal of the American College of Cardiology, 2004
- Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial HypertensionCirculation, 2003
- The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemiaJournal of the American College of Cardiology, 2002
- Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary HypertensionCirculation, 2001
- Oral Sildenafil in the Treatment of Erectile DysfunctionThe New England Journal of Medicine, 1998
- Structure and physiological role of cGMP-dependent protein kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Characterization of the l‐arginine: nitric oxide pathway in human plateletsBritish Journal of Pharmacology, 1990